NEWS
![[Hitnews] ‘New Things, Always By Us!’ Made C&R Research No.1 CRO In South Korea](https://www.cnrres.com/wp-content/uploads/2021/04/CR-CI_홈페이지-기사-업로드용-300x200.png)
[Hitnews] ‘New things, always by us!’ made C&R Research No.1 CRO in South Korea
2024-06-05
'New things, always by us!' made C&R Research No.1 CRO in South Korea. Byungjin Ahn, President of C&R Research,…
[Yakup] C&R Research and ‘Chonnam National University Hwasun Hospital’ signed an MOU to ‘Strengthen Data Utilization in Clinical Research’
2024-06-05
C&R Research and 'Chonnam National University Hwasun Hospital' signed an MOU to 'Strengthen Data Utilization in Clinical Research'. Through…
[Edaily] C&R Research led EMA approval of ‘EYELEA’ Phase 3 IND clinical trial
2024-05-29
C&R Research successfully carried out EMA approval for the Phase 3 IND clinical trial of ‘EYELEA’ Biosimilar with Rophibio, Inc.…
[Global Economic] C&R Research and GC Cell signed an MOU to ‘Strengthen Global Clinical Competitiveness’
2024-04-29
C&R Research and GC Cell signed an MOU to strengthen global clinical competitiveness and sales power. Through this business…
[Hitnews] C&R Research, conducting a Phase 1 clinical trial for ‘Non-Small Cell Lung Cancer’ of ONCOBIX
2024-04-23
C&R Research (CEO Moon-Tae Yoon) announced about conducting a Phase 1 clinical trial for 'Non-Small Cell Lung Cancer' of ONCOBIX…